Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC


Creative Commons License

Hui R., Ozguroglu M., Daniel D., Baz D., Murakami S., Yokoi T., ...Daha Fazla

JOURNAL OF THORACIC ONCOLOGY, cilt.12, sa.11, 2017 (SCI-Expanded, Scopus) identifier